Watching
VECO · Veeco Instruments Inc.
Updated ·
Against its published line
Above its line on the last close.
How to read this
The red mark is the published kill line — the price that would prove the thesis wrong. The dot is where the name closed on 9 October 2026; a dot left of the mark has closed through its line.
Distance is drawn on a square-root scale, so close calls get the room. Past 8% a row reads well clear, with a hollow dot to show the figure is off the drawn scale. Rows run tightest first.
Kill line
A daily close below $49.67, the 25 September 2026 close where the late-September run began; third-quarter 2026 revenue below the $200 million low end of Veeco's guidance would also break the case.
Not a pickResearch coverage at low conviction. A medium-or-higher call would open a pick on the scoreboard.
Catalyst (in 23 days)
How picks are graded →The thesis
Veeco Instruments still closes above the value of the 0.3575 Axcelis shares it would convert into, so a China merger clearance would more likely pull the price down than lift it. The third-quarter report, expected around 4 November 2026, decides whether the standalone order recovery can hold that premium.
Adjusted daily closes show Veeco at $55.67 on 6 October 2026, down from $57.38 on 2 October 2026 and up from $49.67 on 25 September 2026. GuruFocus reported Axcelis down 3.7% at $142.31 on 5 October 2026, after a 6.0% gain to $144.93 on 2 October 2026 (Alphastreet). At both Axcelis prices, 0.3575 Axcelis shares were worth less than one Veeco share. A China clearance would close that gap unless Axcelis rises to meet Veeco.
The narrative is maturing: the order-recovery story is well known since Northland's 21 September 2026 upgrade, no company-specific news has followed it, and the close has eased since the 2 October 2026 sector rally. The 14-day relative strength index (RSI) was 86.2 on 6 October 2026, still overbought after 94.2 on 2 October 2026.
Bullish and bearish views on Veeco Instruments Inc.
The bull case on Veeco Instruments Inc. (VECO), in brief: Revenue guidance points higher. The bear case: The price sits above deal value.
Bull case
- Revenue guidance points higher. Veeco reported second-quarter 2026 revenue of $193.5 million on 5 August 2026, up from $166.1 million a year earlier, and guided third-quarter revenue to $200 million–$220 million.
- Northland's target sits above the price. Northland upgraded Veeco to Outperform on 21 September 2026 with a $66 price target, citing order momentum. The 6 October 2026 close of $55.67 is below that target.
- Chip-equipment makers are rising together. Alphastreet reported Axcelis up 6.0% to $144.93 on 2 October 2026 alongside other equipment makers. A higher Axcelis price raises the value of the merger consideration.
- The merger remains alive. China's State Administration for Market Regulation (SAMR) is the last pending approval, per Axcelis's second-quarter 2026 10-Q. Neither company has announced a prohibition or a termination through 6 October 2026, and the agreement's outside date extends automatically when antitrust approval is the only open condition.
Bear case
- The price sits above deal value. On 6 October 2026 Veeco closed at $55.67, above the value of 0.3575 Axcelis shares at either the 2 October 2026 or 5 October 2026 Axcelis price. Clearance with Axcelis flat would compress that premium.
- Margins fell as sales rose. Veeco's 5 August 2026 release showed second-quarter adjusted gross margin of 39.5%, down from 42.6% a year earlier, and adjusted diluted earnings of $0.33 per share against $0.36.
- Momentum is stretched. RSI read 86.2 on 6 October 2026 after the close climbed from $49.67 on 25 September 2026 to $57.38 on 2 October 2026.
- Insiders have been net sellers. GuruFocus reported on 25 September 2026 that Veeco insiders sold $38.5 million of shares over the prior 12 months with no purchases.
- China's review has dragged on. SAMR first accepted the deal under its simplified procedure on 23 January 2026; MLex reported on 10 July 2026 that the parties moved into normal review after third-party complaints. No decision has been announced since.
Price setup
The 6 October 2026 close of $55.67 sits 33.0% below the 52-week high of $83.04, and the shares are down 3.1% over three months on adjusted daily closes. The late-September run started with a 9.28% gain to $49.67 on 25 September 2026 (GuruFocus) and peaked at $57.38 on 2 October 2026. The pullback to $55.67 leaves the shares above the start of that run. A daily close below $49.67 would erase it and return the price to where it traded before the sector rally.
Catalysts, next 30 days
- ~4 November 2026, est. Veeco third-quarter 2026 report. Revenue against the $200 million–$220 million guidance and adjusted gross margin against the second quarter's 39.5% show whether the standalone business supports a price above the exchange-ratio value.
- Undated — SAMR decision on the Axcelis merger. A clearance converts each Veeco share into 0.3575 Axcelis shares; a prohibition leaves Veeco trading on its own results. Neither company has given a date.
What would change the view
Third-quarter revenue below the $200 million low end of guidance, or adjusted gross margin below 39.5%, would show the standalone recovery cannot carry a premium to deal value. A SAMR clearance announced while Veeco still closes above 0.3575 times Axcelis's close would make convergence toward the Axcelis-linked value the likely path. On the price side, a daily close below $49.67, the 25 September 2026 close where the late-September run began, would end the case. The case would strengthen if Axcelis rose enough that the merger consideration matched or exceeded Veeco's close, or if third-quarter revenue landed at or above the $220 million top of guidance with margin recovering.
What it trades with
Veeco is tied to Axcelis through the fixed 0.3575 exchange ratio, so Axcelis moves set the value of the merger consideration. On 2 October 2026 the two rose with other chip-equipment makers, including Onto Innovation and Amkor, per Alphastreet. That links Veeco to the semiconductor-equipment group (Axcelis, FormFactor, Cohu and peers) and to chip-equipment orders broadly. A group-wide reversal would hit Veeco twice: through its own multiple and through a lower Axcelis-linked value.
Notes
- The merger agreement fixes consideration at 0.3575 Axcelis shares per Veeco share; the market value of that consideration changes with Axcelis' share price.
- The merger agreement's outside date extends automatically when antitrust approval is the only outstanding condition.
- China's SAMR is the final pending approval for the Axcelis–Veeco merger; US, Irish, German and UK clearances were already obtained.
Related · shared themes
TSM
Taiwan Semiconductor Manufacturing Company Ltd.
Taiwan Semiconductor Manufacturing's third-quarter sales of about NT$1.49 trillion beat its own guidance, so the case now rests on margin; the 15 October 2026 report decides whether gross margin holds 65% and fourth-quarter guidance keeps that floor.
AMAT
Applied Materials, Inc.
Applied Materials' chip-equipment recovery case holds as TSMC's September revenue rose 54.6% and Micron raises spending; the 13 October 2026 SEMICON West briefing, TSMC's 15 October 2026 results and the ~12 November 2026 report against a $10.25 billion guide settle it.
ASML
ASML Holding N.V.
ASML Holding's raised €43–45 billion 2026 sales outlook and rising memory-maker spending support its lithography upturn; third-quarter sales against the €11.0–12.0 billion guide on 14 October 2026 settle the near-term case.
COHU
Cohu, Inc.
Cohu's AI-driven chip-test recovery has lifted the shares to $68.37, level with the $70.88 average analyst target; the Q3 report, expected about 29 October 2026, and the 10 November 2026 investor day show whether revenue and new targets justify that price.